T. Rowe Price Investment Management
MRVI icon

T. Rowe Price Investment Management’s Maravai LifeSciences MRVI Stock Holding History

T. Rowe Price Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.83M Sell
1,000,000
-5,336,680
-84% -$18.1M ﹤0.01% 588
2025
Q4 		$20.6M Buy
6,336,680
+178,445
+3% +$601K 0.01% 488
2025
Q3 		$17.7M Buy
6,158,235
+3,514,539
+133% +$8.97M 0.01% 513
2025
Q2 		$6.37M Buy
+2,643,696
New +$5.56M ﹤0.01% 573

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return